NASDAQ:CERN - Cerner Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$62.71 +0.31 (+0.50 %)
(As of 04/19/2019 04:00 PM ET)
Previous Close$62.40
Today's Range$61.86 - $63.0050
52-Week Range$48.78 - $67.57
Volume2.58 million shs
Average Volume2.47 million shs
Market Capitalization$20.34 billion
P/E Ratio28.38
Dividend YieldN/A
Beta0.97
Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. It also provides HealtheIntent platform, a cloud-based platform to aggregate, transform, and reconcile data across the continuum of care; and EHR agnostic platform, CareAware that facilitates connectivity of health care devices to EHRs. In addition, the company offers a portfolio of clinical and financial health care information technology solutions, as well as departmental, connectivity, population health, and care coordination solutions. Further, it provides tech-enabled services, such as implementation and training, remote hosting, operational management services, revenue cycle services, support and maintenance, health care data analysis, clinical process optimization, transaction processing, employer health centers, employee wellness programs, and third-party administrator services; and complementary hardware and devices for third parties. The company serves integrated integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments and public health organizations. It has a strategic collaboration with Christiana Care Health System to provide a weight loss surgery program. Cerner Corporation was founded in 1979 and is headquartered in North Kansas City, Missouri.

Receive CERN News and Ratings via Email

Sign-up to receive the latest news and ratings for CERN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Computer integrated systems design
Sub-IndustryHealth Care Technology
SectorMedical
Current SymbolNASDAQ:CERN
CUSIP15678210
Phone816-221-1024

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.37 billion
Cash Flow$4.2059 per share
Book Value$15.19 per share

Profitability

Net Income$630.05 million

Miscellaneous

Employees29,200
Market Cap$20.34 billion
Next Earnings Date4/25/2019 (Confirmed)
OptionableOptionable

Cerner (NASDAQ:CERN) Frequently Asked Questions

What is Cerner's stock symbol?

Cerner trades on the NASDAQ under the ticker symbol "CERN."

How will Cerner's stock buyback program work?

Cerner announced that its Board of Directors has initiated a stock repurchase plan on Sunday, June 4th 2017, which allows the company to buyback $500,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to purchase up to 2.3% of its stock through open market purchases. Stock buyback plans are usually a sign that the company's management believes its stock is undervalued.

How were Cerner's earnings last quarter?

Cerner Co. (NASDAQ:CERN) posted its earnings results on Tuesday, February, 5th. The company reported $0.63 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.57 by $0.06. The firm earned $1.37 billion during the quarter, compared to analyst estimates of $1.39 billion. Cerner had a return on equity of 14.84% and a net margin of 11.74%. The firm's revenue was up 3.9% on a year-over-year basis. During the same quarter last year, the business posted $0.58 EPS. View Cerner's Earnings History.

When is Cerner's next earnings date?

Cerner is scheduled to release their next quarterly earnings announcement on Thursday, April 25th 2019. View Earnings Estimates for Cerner.

What guidance has Cerner issued on next quarter's earnings?

Cerner issued an update on its FY19 earnings guidance on Tuesday, February, 5th. The company provided EPS guidance of $2.57-2.67 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.68. The company issued revenue guidance of $5.650-5.850 billion, compared to the consensus revenue estimate of $5.80 billion.Cerner also updated its FY 2019 guidance to $2.57-2.67 EPS.

What price target have analysts set for CERN?

14 Wall Street analysts have issued 12-month price objectives for Cerner's stock. Their forecasts range from $49.00 to $77.00. On average, they anticipate Cerner's share price to reach $69.00 in the next year. This suggests a possible upside of 10.0% from the stock's current price. View Analyst Price Targets for Cerner.

What is the consensus analysts' recommendation for Cerner?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cerner in the last year. There are currently 1 sell rating, 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cerner.

What are Wall Street analysts saying about Cerner stock?

Here are some recent quotes from research analysts about Cerner stock:
  • 1. Cantor Fitzgerald analysts commented, "Our rating remains Overweight and our PT remains $75. Although some amount of investor skepticism regarding the company’s growth outlook continues to temper valuation levels, we do not share those concerns. Our long-term DCF model assumptions are mostly conservative, with high single-digit revenue growth and modest margin expansion. Capital spending should moderate in 2019. We think the shares offer a compelling risk/reward trade off. Valuation Summary Cerner shares trade at a 32% discount to our DCF-based price target of $75." (4/9/2019)
  • 2. According to Zacks Investment Research, "Cerner continues to witness strong contributions from its key areas, including Population Health, Revenue Cycle and IT Works. Strong international performance in recent times is an added positive. Further, gains in Professional and Managed Services units buoy optimism. The company is likely to benefit from EHR, EPR or EMR platforms that provide patient care in both acute inpatient and outpatient settings. On the flip side, the company’s Licensed Software and Subscriptions revenues witnessed a year-over-year decline in the last reported quarter. In fact, management expects low software bookings to negatively impact total bookings in the upcoming quarter. The contraction in operating margin adds to the woes. Furthermore, high long-term debt and competition in the global HCIT space are worrisome. Cerner has underperformed its industry in a year's time." (4/8/2019)

Has Cerner been receiving favorable news coverage?

News stories about CERN stock have trended positive recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Cerner earned a media sentiment score of 2.7 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 5.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the company's share price in the immediate future.

Who are some of Cerner's key competitors?

What other stocks do shareholders of Cerner own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cerner investors own include Dominion Energy (d), Cisco Systems (CSCO), Gilead Sciences (GILD), QUALCOMM (QCOM), Celgene (CELG), NVIDIA (NVDA), Intel (INTC), Micron Technology (MU), Netflix (NFLX) and Alibaba Group (BABA).

Who are Cerner's key executives?

Cerner's management team includes the folowing people:
  • Mr. Marc G. Naughton, Exec. VP & CFO (Age 64)
  • Mr. Michael R. Nill, Exec. VP & COO (Age 54)
  • Mr. Jeffrey A. Townsend, Exec. VP & Chief of Innovation (Age 55)
  • Mr. David Brent Shafer, Chairman & CEO (Age 62)
  • Mr. Michael Robin, Partner and VP

Who are Cerner's major shareholders?

Cerner's stock is owned by many different of institutional and retail investors. Top institutional investors include LGT Capital Partners LTD. (0.36%), Global Thematic Partners LLC (0.19%), Confluence Investment Management LLC (0.14%), Reinhart Partners Inc. (0.09%), Capital Investment Services of America Inc. (0.07%) and Rockland Trust Co. (0.05%). Company insiders that own Cerner stock include Clifford W Illig, David Brent Shafer, Denis A Cortese, Gerald E Bisbee, Jr, Jeffrey A Townsend, Julie M Wilson, Linda M Dillman, Marc G Naughton, Michael Nill, Michael R Battaglioli, Neal L Patterson, Randy D Sims, William D Zollars and Zane M Burke. View Institutional Ownership Trends for Cerner.

Which institutional investors are selling Cerner stock?

CERN stock was sold by a variety of institutional investors in the last quarter, including Autus Asset Management LLC, Prime Capital Investment Advisors LLC, Trust Department MB Financial Bank N A, DNB Asset Management AS, Altfest L J & Co. Inc., First Hawaiian Bank, Cambridge Advisors Inc. and Beacon Financial Group. Company insiders that have sold Cerner company stock in the last year include Clifford W Illig, David Brent Shafer, Denis A Cortese, Julie M Wilson, Linda M Dillman, Michael R Battaglioli, William D Zollars and Zane M Burke. View Insider Buying and Selling for Cerner.

Which institutional investors are buying Cerner stock?

CERN stock was bought by a variety of institutional investors in the last quarter, including Confluence Investment Management LLC, Pacer Advisors Inc., LGT Capital Partners LTD., Cardinal Capital Management, Mercer Global Advisors Inc. ADV, BTIM Corp., Bell Asset Management Ltd and Pennsylvania Trust Co. View Insider Buying and Selling for Cerner.

How do I buy shares of Cerner?

Shares of CERN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cerner's stock price today?

One share of CERN stock can currently be purchased for approximately $62.71.

How big of a company is Cerner?

Cerner has a market capitalization of $20.34 billion and generates $5.37 billion in revenue each year. The company earns $630.05 million in net income (profit) each year or $2.21 on an earnings per share basis. Cerner employs 29,200 workers across the globe.

What is Cerner's official website?

The official website for Cerner is http://www.cerner.com.

How can I contact Cerner?

Cerner's mailing address is 2800 ROCKCREEK PKWY W0162, NORTH KANSAS CITY MO, 64117. The company can be reached via phone at 816-221-1024 or via email at [email protected]


MarketBeat Community Rating for Cerner (NASDAQ CERN)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  894 (Vote Outperform)
Underperform Votes:  565 (Vote Underperform)
Total Votes:  1,459
MarketBeat's community ratings are surveys of what our community members think about Cerner and other stocks. Vote "Outperform" if you believe CERN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CERN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel